Asher Mullard

529 papers receiving 8.4k citations

Asher Mullard's Hit Papers

2023 FDA approvals 2024 · 100 citations
1000+1Years since publication255075100

Peers

Asher Mullard
Comparison fields: 5 of 166
  • Pharmaceutical Science 353
  • Computational Theory and Mathematics 818
  • Oncology 997
  • Molecular Biology 2.1k
  • Immunology 537
Replace William G. Bornmann with:
William G. Bornmann United States
Yoshio Hayashi Japan
Peter N. Kirkpatrick United States
Kit S. Lam United States
Shengyong Yang China
Anton Simeonov United States
Matthew D. Hall United States
Dennis A. Smith United Kingdom
Rodney Kiplin Guy United States
Alexander S. S. Dömling Netherlands
Asher Mullard relative to William G. Bornmann United States William G. Bornmann's profile →
Citations per field
00.5×2×2.8×
William G. Bornmann · 1×
Citations per year

Countries citing papers authored by Asher Mullard

Since Specialization
Citations

This map shows the geographic impact of Asher Mullard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asher Mullard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asher Mullard more than expected).

Fields of papers citing papers by Asher Mullard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asher Mullard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asher Mullard. The network helps show where Asher Mullard may publish in the future.

Co-authors

The 25 scholars most cited alongside Asher Mullard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Asher Mullard Line = papers co-authored together Asher Mullard links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 559 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2004268
2 2006267
3 2013246
4 2016232
5 2012211
6 2020184
7 2017166
8 2014161
9 2021157
10 2012139
11 2018119
12 2016117
13 2013115
14 2021104
15 2017103
16 2022103
17 2021102
18 2015100
19
2023 FDA approvals
Hit paper breakdown →
2024100
20 202098

About Asher Mullard

Asher Mullard is a scholar working on Economics and Econometrics, Oncology, Physiology, Molecular Biology and Infectious Diseases, having authored 559 papers that have together received 8.8k indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (106 papers), Cancer Immunotherapy and Biomarkers (35 papers), Computational Drug Discovery Methods (25 papers), Monoclonal and Polyclonal Antibodies Research (24 papers), Alzheimer's disease research and treatments (24 papers), SARS-CoV-2 and COVID-19 Research (22 papers), Pharmaceutical industry and healthcare (20 papers) and Protein Degradation and Inhibitors (19 papers). The work is most often cited by research in Pharmaceutical Science (353 citations), Computational Theory and Mathematics (818 citations), Oncology (997 citations), Molecular Biology (2.1k citations) and Immunology (537 citations). Asher Mullard has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Alaa El-Husseini, Rujun Kang, Anat Yanai, Kun Huang, Michael R. Hayden, Roshni Rebecca Singaraja, Pamela Arstikaitis, Martina Metzler, Brendan Haigh and Claire‐Anne Gutekunst. Their work appears in journals such as Nature Reviews Drug Discovery, Nature, The Lancet, Nature Reviews Molecular Cell Biology and Nature Biotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact